Alignment Healthcare (ALHC) Earnings Analysis
Alignment Healthcare (ALHC) next reports earnings on 2026-07-30, consensus EPS 0.13 USD. Last quarter (2026-04-30) it beat with EPS 0.05 USD vs 0.01 USD est (+400%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 210.86.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ALHC next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.13 USD |
| Revenue estimate | 1.31B |
ALHC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.05 USD | 0.01 USD | +400% | Beat |
| 2026-02-26 | -0.05 USD | -0.15 USD | +66.7% | Beat |
| 2025-10-30 | 0.02 USD | -0.01 USD | +300% | Beat |
| 2025-07-30 | 0.07 USD | -0.07 USD | +200% | Beat |
| 2025-05-01 | -0.05 USD | -0.12 USD | +58.3% | Beat |
| 2025-02-27 | -0.16 USD | -0.18 USD | +11.1% | Beat |
| 2024-08-01 | -0.13 USD | -0.14 USD | +7.1% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
ALHC valuation and analyst view
| Trailing P/E | 210.86 |
|---|---|
| Trailing EPS | 0.09645 USD |
| Price / book | 20.62 |
| Dividend yield | 0.00% |
| Market cap | 4.32B |
| Analyst consensus | Buy (14 buy / 2 hold / 0 sell) |
| Avg price target | 19.75 USD |
Related research pages
Frequently asked questions
When is Alignment Healthcare (ALHC)'s next earnings date?
Alignment Healthcare is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.13 USD and revenue estimate of 1.31B.
Did ALHC beat earnings last quarter?
In its 2026-04-30 report, ALHC posted EPS of 0.05 USD versus a 0.01 USD estimate — a beat of 400%.
What is ALHC's earnings track record?
Over the last 7 reported quarters with consensus data, ALHC beat estimates 7 times (100%).
What is ALHC's current P/E ratio and EPS?
ALHC trades at a trailing P/E of 210.86 on trailing EPS of 0.09644695899100723 USD.
What do analysts rate ALHC?
Analyst consensus is "Buy" across 16 ratings (1 strong buy, 13 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 19.75 USD.